PATENT CLAIM ANALYSIS

Application Number: 16032270
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "400000"]

Abstract:
Injectable depot compositions, comprising a biocompatible polymer which is a polymer or copolymer based on lactic acid and/or lactic acid plus glycolic acid having a monomer ratio of lactic to glycolic acid in the range from 48:52 to 100:0, a water-miscible solvent having a dipole moment of about 3.7-4.5 D and a dielectric constant of between 30 and 50, and a drug, were found suitable for forming in-situ biodegradable implants which can evoke therapeutic drug plasma levels from the first day and for at least 14 days.

Claim (Index 23):
The method of  claim 1 , wherein the injectable composition is administered to the subject every four weeks, every five weeks, every six weeks, every two months, every three months, every four months, every five months, or every six months.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 95.0
- Lexical Diversity: 1.4375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13690707', '15944894', '13690647', '14555287', '14610362']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8166035384872871
- 35 USC 102 Novelty (BERT): 0.6071665457535534
- Combined Prediction Score: 0.7956598392139137
- Mean Citation Score: 493.552822
- Max Citation Score: 740.9466
- Similarity Product: 454.6787631922245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test